yes now the ongoing cash for ACR is going to be compromised. If they win the appeal it's different.
Looks like Eli Lilly doesn't want to pay for the FDA safety study.
Cash backing right now is ~20c
- Forums
- ASX - By Stock
- Ann: Teva Launches Generic Version of Axiron in United States
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.6¢

yes now the ongoing cash for ACR is going to be compromised. If...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.524M |
Open | High | Low | Value | Volume |
1.5¢ | 1.6¢ | 1.5¢ | $9.887K | 624.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6355 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6355 | 0.016 |
4 | 559314 | 0.015 |
3 | 420000 | 0.014 |
2 | 397000 | 0.013 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 20000 | 1 |
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 50000 | 1 |
0.021 | 203466 | 1 |
Last trade - 15.00pm 26/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online